Beacon Pointe Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Beacon Pointe Advisors’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-34,250	Closed	-$17K	–	594
2020 Q4	$17K	Hold	34,250	–	–	﹤0.01%	508
2020 Q3	$19K	Sell	34,250 -45,500	-57%	-$32.7K	﹤0.01%	400
2020 Q2	$55K	Buy	+79,750	New	+$64.1K	0.01%	395

Other funds holding GEN

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Beacon Pointe Advisors's GEN Position: Q1 2021 in Review

Beacon Pointe Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 34,250 shares — an estimated $17K sold.

Beacon Pointe Advisors first reported a position in GEN in Q2 2020 and held it in 3 quarters. The position peaked at $55K in Q2 2020. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

Beacon Pointe Advisors reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
Beacon Pointe Advisors sold 34,250 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $17K.
Beacon Pointe Advisors first reported a position in Genesis Healthcare, Inc. in Q2 2020 and held it in 3 quarters.
Beacon Pointe Advisors's Genesis Healthcare, Inc. position peaked at $55K in Q2 2020.
8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Beacon Pointe Advisors's 13F filing for Q1 2021, filed 18 May 2021.